Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Association of Elevations of Specific T Cell and Monocyte Subpopulations in Rheumatoid Arthritis With Subclinical Coronary Artery Atherosclerosis.

Winchester R, Giles JT, Nativ S, Downer K, Zhang HZ, Bag-Ozbek A, Zartoshti A, Bokhari S, Bathon JM.

Arthritis Rheumatol. 2016 Jan;68(1):92-102. doi: 10.1002/art.39419.

2.

Psychometric properties of a new treatment expectation scale in rheumatoid arthritis: an application of item response theory.

Ibrahim F, Ayis S, Hofmann D, Rose D, Wykes T, Cope A, Scott DL, Lempp H.

BMC Musculoskelet Disord. 2015 Sep 4;16:239. doi: 10.1186/s12891-015-0690-3.

3.

The reliability and validity of the English version of the Evaluation of Daily Activity Questionnaire for people with rheumatoid arthritis.

Hammond A, Tennant A, Tyson SF, Nordenskiƶld U, Hawkins R, Prior Y.

Rheumatology (Oxford). 2015 Sep;54(9):1605-15. doi: 10.1093/rheumatology/kev008. Epub 2015 Apr 10.

4.

Progression of coronary artery atherosclerosis in rheumatoid arthritis: comparison with participants from the Multi-Ethnic Study of Atherosclerosis.

Chung CP, Giles JT, Kronmal RA, Post WS, Gelber AC, Petri M, Szklo M, Detrano R, Budoff MJ, Blumenthal RS, Ouyang P, Bush D, Bathon JM.

Arthritis Res Ther. 2013 Sep 25;15(5):R134. doi: 10.1186/ar4314.

5.

Prevalence of traditional modifiable cardiovascular risk factors in patients with rheumatoid arthritis: comparison with control subjects from the multi-ethnic study of atherosclerosis.

Chung CP, Giles JT, Petri M, Szklo M, Post W, Blumenthal RS, Gelber AC, Ouyang P, Jenny NS, Bathon JM.

Semin Arthritis Rheum. 2012 Feb;41(4):535-44. doi: 10.1016/j.semarthrit.2011.07.004.

6.

Disparity in disaster preparedness among rheumatoid arthritis patients with various general health, functional, and disability conditions.

Tomio J, Sato H, Mizumura H.

Environ Health Prev Med. 2012 Jul;17(4):322-31. doi: 10.1007/s12199-011-0257-3. Epub 2011 Dec 21.

7.

Measurement properties of physical function scales validated for use in patients with rheumatoid arthritis: a systematic review of the literature.

Oude Voshaar MA, ten Klooster PM, Taal E, van de Laar MA.

Health Qual Life Outcomes. 2011 Nov 7;9:99. doi: 10.1186/1477-7525-9-99. Review.

8.

Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity.

Solomon DH, Kremer J, Curtis JR, Hochberg MC, Reed G, Tsao P, Farkouh ME, Setoguchi S, Greenberg JD.

Ann Rheum Dis. 2010 Nov;69(11):1920-5. doi: 10.1136/ard.2009.122226. Epub 2010 May 5.

9.

Measure of function in rheumatoid arthritis: individualised or classical scales?

Seror R, Tubach F, Baron G, Guillemin F, Ravaud P.

Ann Rheum Dis. 2010 Jan;69(1):97-101. doi: 10.1136/ard.2008.102137.

10.

Use of complementary and alternative medicine among patients with arthritis.

Callahan LF, Wiley-Exley EK, Mielenz TJ, Brady TJ, Xiao C, Currey SS, Sleath BL, Sloane PD, DeVellis RF, Sniezek J.

Prev Chronic Dis. 2009 Apr;6(2):A44. Epub 2009 Mar 16.

11.

Functional improvement after patients with rheumatoid arthritis start a new disease modifying antirheumatic drug (DMARD) associated with frequent changes in DMARD: the CORRONA database.

Ranganath VK, Paulus HE, Onofrei A, Khanna D, Reed G, Elashoff DA, Kremer JM, Furst DE.

J Rheumatol. 2008 Oct;35(10):1966-71. Epub 2008 Sep 1.

12.
13.

How to create a new consensus on quality improvement measures in health care.

Fisher WP Jr.

MedGenMed. 2006 Dec 11;8(4):51. No abstract available.

14.

Sensitivity to change of AIMS2 and AIMS2-SF components in comparison to M-HAQ and VAS-pain.

Taal E, Rasker JJ, Riemsma RP.

Ann Rheum Dis. 2004 Dec;63(12):1655-8.

15.

The determination and measurement of functional disability in rheumatoid arthritis.

Wolfe F.

Arthritis Res. 2002;4 Suppl 2:S11-5. Epub 2002 Apr 8. Review.

Supplemental Content

Support Center